Factors associated with yellow fever vaccine failure: A systematic literature review

• Published in: Vaccine 2023-03, Vol.41 (13), p.2155-2169
• Main Authors: Fantinato, Francieli Fontana Sutile Tardetti, Wachira, Virginia Kagure, Porto, Victor Bertollo Gomes, Peixoto, Henry Maia, Duarte, Elisabeth Carmen
• Format: Article
• Language: English
• Subjects: Antibodies; Child; Citation management software; Clinical trials; Cohort analysis; Epidemics; Epidemiology; Failure; Failure analysis; Female; Fever; Health sciences; HIV; Human immunodeficiency virus; Humans; Immunization; Immunization Schedule; Immunosuppression Therapy; Immunosuppressive agents; Infant; Literature reviews; Measles; Medical personnel; Medical research; Pregnancy; Qualitative analysis; Rubella; Vaccination - adverse effects; Vaccines; Vector-borne diseases; Yellow fever; Yellow Fever - prevention & control; Yellow Fever Vaccine - adverse effects; Yellow fever virus
• ISSN: 0264-410X; 1873-2518
• DOI: 10.1016/j.vaccine.2023.02.007

Considering that vaccination with yellow fever vaccine (YFV) is the most important method to prevent and control yellow fever (YF), this study synthesized evidence on factors associated with YFV failure. A systematic review (SR) was performed in the PubMed, Cochrane CENTRAL, Embase, and LILACS databases up to November 2019. Observational and experimental analytical epidemiological studies that analyzed the failure of YFV were included. This review followed the guidelines of the Preferred Reporting Items for Systematic Reviews and meta-Analyses. A total of 1,466 articles were identified after searching the databases of which 46 were included in the qualitative analysis after applying the elegibility criteria. Our findings indicated that YFV confers protective immunity in different age groups; when produced by different producers; when administered simultaneously with a range of other vaccines; when used as fractional doses and when used with prophylactic and immunosuppressive therapies. It failed to produce a protective response in some pregnant women, children under two years of age, children with Kwashiorkor and when long periods of time have passed after vaccination. For individuals with human immunodeficiency virus (HIV), the results were divergent. The results of this SR revealed the factors associated with the failure of the YFV, and the results can support recommendations on vaccination policies, support the safety of health professionals who work directly with immunization in the implementation of the vaccination schedule, in addition to guiding future research and enhance the credibility of YFV in the prevention of a serious disease such as YF.